Jeuveau

Chemical NameprabotulinumtoxinA-xvfs
Dosage FormInjectable (intramuscular; 100 units/vial)
Drug ClassInhibitors
SystemMusculoskeletal
CompanyEvolus
Approval Year2019

Indication

  • Jeuveau is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
Last updated on 11/9/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?